Drug Trial Radar · NCT06237309
REGN5381 in Adult Participants With Heart Failure With Reduced Ejection Fraction
Last checked: Nov 19, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
89
Actual
Start
Apr 11, 2024
Primary completion
Sep 17, 2025
Study completion Dec 29, 2025
Sponsor
- Lead sponsor
- Regeneron PharmaceuticalsRegeneron (REGN)
- Sponsor type
- Industry
- First posted
- Feb 1, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is researching an experimental drug called REGN5381 (called "study drug"). The study is focused on patients with heart failure with reduced ejection fraction (ie, the heart is not functioning as well as it should). The aim of the study is to see how safe, tolerable, and effective the study drug is. The study is looking at several other research questions, including: * What side effects may happen from taking the study drug * How much study drug is in the blood at different times * Whether the body makes antibodies against the study drug (which could make the study drug less effective or could lead to side effects)
Conditions
- Heart Failure
Interventions
REGN5381Drug
Single dose intravenous (IV) infusion
PlaceboDrug
Single dose IV infusion
Primary outcomes
What the sponsor says the trial is designed to measure.
- Fold Change From Baseline in Circulating N-Terminal Pro-Brain Natriuretic Peptide (NTproBNP)Time frame: Baseline, Day 8
Locations
44 sites in 12 countries. Site status is shown where the registry gives one.
Arensia Exploratory Medicine Clinic
Phoenix, Arizona
Harbor UCLA Medical Center
Torrance, California
Flourish Research - Miami (Kendall) (Formerly Clinical Site Partners)
Miami, Florida
Flourish Research - Orlando (Formerly Clinical Site Partners)
Winter Park, Florida
Centre Hospitalier Regional de la Citadelle
Liège, Belgium
Grand Hopital de Charleroi
Gilly, Hainaut, Belgium
Anima Research Center
Alken, Limburg, Belgium
Onze Lieve Vrouw Ziekenhuis Aalst
Aalst, Oost-Vlaanderen, Belgium
UZ Leuven
Leuven, Vlaams Brabant, Belgium
Algemeen Ziekenhuis St Jan Brugge Oostende Av
Bruges, West Flanders, Belgium
Algemeen Ziekenhuis Groeninge
Kortrijk, West Vlaanderen, Belgium
AZ Oostende
Ostend, West Vlaanderen, Belgium
MHAT Haskovo
Haskovo, Bulgaria
University Multiprofile Hospital for Active Treatment Plovdiv
Plovdiv, Bulgaria
Arensia Exploratory Medicine Clinic at MBAL Sveta Sofia
Sofia, Bulgaria
Medicus Services s.r.o.
Brandýs nad Labem-Stará Boleslav, Czechia
Edumed
Jaroměř, Czechia
Fakultni Nemocnice v Motole
Prague, Central Bohemian, Czechia
University Hospital Brno
Brno, South Moravian, Czechia
Arensia Exploratory Medicine at the Research Institute of Clinical Medicine
Tbilisi, Georgia
General University Hospital Attikon
Chaïdári, Greece
Larissa University Hospital
Larissa, Greece
First Cardiology Clinic University of Athens
Athens, Attica, Greece
Athens Naval Hospital
Athens, Attikh, Greece
Pmsi Republican Clinical Hospital Timofei Mosneaga
Chisinau, Moldova
Medical University of Lodz
Lodz, Poland
NZOZ Gemini
Żychlin, Poland
Wojewodzki Szpital Zespolony - Ludwik Rydygier Provincial Hospital
Torun, Kuyavian-Pomeranian Voivodeship, Poland
Clinmedica Research sp zo.o.
Skierniewice, Łódź Voivodeship, Poland
UCK Medical University of Warsaw
Warsaw, Masovian Voivodeship, Poland
Arensia Exploratory Medicine Clinic at Monza Bucharest
Bucharest, Romania
Sc Arensia Exploratory Medicine Srl
Cluj-Napoca, Romania
Worthwhile Clinical Trials
Benoni, Gauteng, South Africa
Into Research
Groenkloof, Gauteng, South Africa
Dr M I Sarvan,R Moodley & partners
Durban, KwaZulu-Natal, South Africa
Kuils River Hospital
Kuils River, Western Cape, South Africa
Korea University Guro Hospital
Seoul, South Korea
Wonju Severance Christian Hospital
Wŏnju, Gangwon-do, South Korea
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea
Severance Hospital at Yonsei University College of Medicine
Seoul, Seodaemun-gu, South Korea
Showing 40 of 44 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.